Linguistic Disparities Impact Patient Access to Cancer Care
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 8, 2023 -- For non-English-speaking patients, linguistic disparities affect access to cancer care, according to a study published in the September issue of the Journal of the National Comprehensive Cancer Network.
Debbie W. Chen, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues conducted a study involving trained investigators who were assigned to the roles of English-, Spanish-, and Mandarin-speaking patients who called the general information telephone line of 144 hospitals located across 12 demographically diverse states. Callers were looking to access care for three cancer types that disproportionately impact Hispanic and Asian populations (colon, lung, and thyroid cancers). The primary outcome was whether the simulated patient caller was provided with the next steps to access cancer care.
The researchers found that 52.9 percent of the 1,296 calls resulted in the simulated patient callers being provided with the next steps to access cancer care. Compared with English-speaking patient callers, non-English-speaking callers were significantly less likely to be provided with the next steps (Mandarin, 27.5 percent; Spanish, 37.7 percent; English, 93.5 percent). Significant associations for the primary outcome were seen for language spoken (odds ratios, 0.02 and 0.04 for Mandarin and Spanish, respectively) and for hospital teaching status (odds ratio, 0.43 for nonteaching versus teaching).
"It is essential that we take a critical look at our health care system and engage in efforts to mitigate these communication barriers that disproportionately impact the health of vulnerable patient populations with cancer," the authors write. "All patients with cancer should have access to high-quality medical and surgical care, regardless of English language proficiency."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.